NUCRYST Pharmaceuticals Corp. Board Compensation

Executive Compensation Plan Agreement

You are currently viewing:

This Executive Compensation Plan Agreement involves

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.

Title: NUCRYST Pharmaceuticals Corp. Board Compensation
Date: 8/5/2009
Industry: Medical Equipment and Supplies Sector: Healthcare

Exhibit 10.73

May 2009

NUCRYST Pharmaceuticals Corp.

Board Compensation




Category	NUCRYST Plan	*Annual Value ( approx.* )**



Initial Equity Grant	5,000 Restricted Shares	n/a ⁽¹⁾
	(immediate vesting, with 1,000 available for sale in
	1 year and 4,000 to be held for duration of board service)
	8,000 Stock Options



Annual Retainer	$15,000	$5,000
(Paid quarterly excluding
Chairman of the Board)



Board Meeting Fees	$2,000/meeting	$12,000 (assumes 6 meetings/year)
(including telephone meetings)



Annual Stock Award	3,000 Restricted Shares	$2,750 ⁽²⁾
	(50% vest after 1 year and 50% after second year)
	2,000 Stock Options	Total Annual Board Comp. - $29,750 [TBD – based
		on share price change]



Chairman of the Board Retainer	$100,000	$100,000
(Paid quarterly and in lieu of board and committee meeting fees)



Committee Chair Annual Retainer	$7,500 for Audit	$7,500 Audit Chair
( Paid quarterly )	$5,000 for Governance, Nominating & Compensation	$5,000 Governance, Nominating and Compensation Chair



Committee Meeting Fees	Audit	Assumes 6 Audit Committee Meetings per year
(including telephone meetings)	Chair – $1,500/meeting	Chair – $9,000
	Member – $1,200/meeting	Member – $7,200
	Governance, Nominating and Compensation Committee	Assumes 4 Governance, Nominating and Compensation
	Chair – $1,000/meeting	Committee meetings per year for
	Member – $800/meeting	Chair – $4,000
		Member – $3,200

		Total Annual Committee Comp. – $19,700

		Total Annual Co

SITE SEARCH

Get Email Updates